On 3/1/24, Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 13.5%, closing at $20.58. However, below average trading volume at 73% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 28.6% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, CBIO is expected to be a major Value Eraser.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment